Seraxis is a privately owned biotechnology company. Our GMP lab is located in Germantown, Maryland, in the heart of the vibrant BioHealth Capital Region. Launched in early 2013, Seraxis used proprietary technologies to develop a cell replacement therapy, SR-01, that is more effective and safer than embryonic stem cell-derived therapies. Our highly pure insulin-producing cells are micro-encapsulated through a proprietary technology that enables the function of human pancreas cells in type-1 diabetes models without the need for immuno-suppression. Seraxis intends to bring SR-01 to the clinic in order to provide a cure for the devastating disease of diabetes.
View Top Employees from SeraxisWebsite | http://www.seraxis.com |
Revenue | $6 million |
Employees | 24 (14 on RocketReach) |
Founded | 2013 |
Address | 20271 Goldenrod Lane Suite 2085, Germantown, Maryland 20876, US |
Phone | (240) 429-1053 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Business Services |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies |
Looking for a particular Seraxis employee's phone or email?
The Seraxis annual revenue was $6 million in 2024.
Paul Strumph is the Chief Medical Officer of Seraxis.
14 people are employed at Seraxis.
Seraxis is based in Germantown, Maryland.
The NAICS codes for Seraxis are [541, 54, 5417, 541714, 54171].
The SIC codes for Seraxis are [87, 873].